While several studies have assessed the impact of the COVID-19 pandemic on sexuality and sexual behavior in the general population, very few studies have assessed sexuality after Sars-Cov 2 infection.

The objective of our study were to assess sexuality in women recovered from COVID-19 and to compare it to healthy controls.

This is a cross-sectional case-control study.

We randomly recruited women, from April 1st to 30th, 2021.The women in the case group have been infected with Sars-Cov 2, with a benign or pauci-symptomatic clinical form, and cured for one to two months at the time of the study without any post-COVID complications. Women included in the control group have not been infected with Sars-Cov 2. Sexuality was assessed by the Female Sexual Function Index (FSFI).

In total, we recruited 30 women in the case group and 30 women in the control group.The average age of the case group was 35.8 ±6.8 years versus an average age of 35.3 ± 6.33 years in the control group. The majority of coronavirus infections were symptomatic (83.3% (n=25)). An FSFI score <26.55 and corresponding to impaired sexual function was found in 63.33% of women in the case group (n=19), versus 53.33% of women in the control group (n=16) with a significant difference between the two groups (p=0.009)

COVID-19 is significantly associated with sexual dysfunction, even in mild or pauci-symptomatic clinical forms.

No significant relationships.

Studies assessing the psychological impact of COVID-19 have shown that patients with COVID-19 had significantly higher levels of depression, anxiety, and post-traumatic stress symptoms than healthy controls.

The objectives of our study were to assess depression in women recovered from COVID-19 and to compare it to healthy controls.

It was a cross-sectional case-control study.

We randomly recruited women, from April 1st to 30th, 2021.The women in the case group have been infected with Sars-Cov 2, with a benign or pauci-symptomatic clinical form, and cured for one to two months at the time of the study without any post-COVID complications. Women included in the control group have not been infected with Sars-Cov 2 .Depression was assessed by the Beck Depression Inventory (BDI).

In total, we recruited 30 women in the case group and 30 women in the control group.The average age of the case group was 35.8 ±6.8 years versus an average age of 35.3 ± 6.33 years in the control group. The majority of coronavirus infections were symptomatic (83.3% (n=25)).

The average depression score for the case group was 10.8 ±9.6 corresponding to moderate depression, while the average depression score for the control group was 6.1 ± 6.1 corresponding to mild depression. The presence of depression was more significant in the case group compared to the controls (p=0.003).

COVID-19 is significantly associated with depression, even in mild or pauci-symptomatic clinical forms.

No significant relationships.

Studies assessing the psychological impact of COVID-19 have shown that patients with COVID-19 had significantly higher levels of depression, anxiety, and post-traumatic stress symptoms than healthy controls.

The objectives of our study were to assess dysfunctional anxiety in women recovered from COVID-19 and to compare it to healthy controls.

This is a cross-sectional case-control study.

We randomly recruited women, from April 1st to 30th, 2021.The women in the case group have been infected with Sars-Cov 2, with a benign or pauci-symptomatic clinical form, and cured for one to two months at the time of the study without any post-COVID complications. Women included in the control group have not been infected with Sars-Cov 2 .Anxiety was assessed by the Coronavirus Anxiety Scale (CAS).

In total, we recruited 30 women in the case group and 30 women in the control group.The average age of the case group was 35.8 ±6.8 years versus an average age of 35.3 ± 6.33 years in the control group. The majority of coronavirus infections were symptomatic (83.3% (n=25)). Nearly one-third of the patients in the case group had a CAS score greater than 9, indicating dysfunctional anxiety probably related to coronavirus (33.3%), with a significant difference with the control group (p=0.026).

COVID-19 is significantly associated with dysfunctional anxiety, even in mild or pauci-symptomatic clinical forms.

No significant relationships.